SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " cardi " 1,796 found 🔀 AI-powered Shuffle
2026 BET Awards: The 5 biggest moments of celebration and remembrance
Family and sisterhood were on display at the 2026 BET Awards at the Peacock Theater with wins for Cardi B, SZA and Doechii, and tributes to D'Angelo and Lauryn Hill.
Radford University finalizing plan to build new health sciences center on Roanoke’s Jefferson Street
The new building would house all Radford University Carilion programs, a university spokesperson said.
AHA/ACC/ESC/WHF Expert Consensus Document in Collaboration with HFSA, HFA and JHFS: Second Universal Definition of Heart Failure (2026)
In response to the rising global prevalence of heart failure (HF) and limitations in research, surveillance, and prevention, in 2021 multiple cardiac societies convened to issue the First Universal Definition of Heart Failure, establishing uniform terminology, including a designated Stage B (pre-HF) to identify at-risk individuals.
Student-athlete ECG law takes effect July 1; families share why it's needed
Florida is the first state to require electrocardiogram (ECG) screenings for high school athletes. It is called the Second Chance Act.
Rams news: QB battle, power rankings, top 100, power rankings
Some stories about the NFC West rival LA Rams from the last week for Arizona Cardinals fans to know.
Read Live Updates From The 2026 BET Awards
Cardi B, Doechii, Jill Scott, Kehlani and more are set to take the stage on culture's biggest night.
Efzimfotase alfa demonstrated improvements in bone health in treatment-naïve pediatric patients with hypophosphatasia achieving median difference of 1.67 vs placebo in RGI-C Score at week 25 in MULBERRY Phase III trial
Positive results from the MULBERRY Phase III trial showed that efzimfotase alfa (ALXN1850), an investigational enzyme replacement therapy, demonstrated a statistically significant and clinically meaningful improvement in bone health in children (2 to
Leo XIV’s second “business” consistory produced few headlines, but that’s by design
On Saturday, Pope Leo XIV brought an end to the second extraordinary consistory of his pontificate. The meeting of cardinals was not very exciting, which might have been the point.
78 days till Arizona Cardinals' opener: Remembering the 1978 season
With 78 days until the Arizona Cardinals' 2026 opener, let's look back at their 1978 season.
3 foods that seem healthy but may be bad for your heart: cardiologist
A cardiologist said popular "healthy" foods can actually be bad for your heart, since they're highly processed and full of additives like sugar and fat.
Just 2 Hours of Strength Training May Lower Heart Disease Risk in Women
Researchers say that just 2 hours of weekly strength training may help lower the risk of cardiovascular disease in women, especially when paired with 150 minutes of weekly aerobic exercise.
Cardinals' Dustin May: Next start getting skipped
Cardinals' Dustin May: Next start getting skipped
Americans keep poisoning themselves with semaglutide, other weight loss drugs
These incidents became much more common after the FDA started approving GLP-1 drugs for chronic weight management in 2021.
Why where you live matters for heart health — even in childhood - Baylor College of Medicine Blog Network
Evidence links environmental exposures to early cardiovascular risk, disproportionately impacting marginalized communities like AI/AN youth.
CRAWFORD | Kenny Klein, beloved longtime Louisville sports information director, dies at 66
Klein's career spanned nearly four decades and helped shape the public face of Cardinals athletics through some of its greatest triumphs and most difficult crises.
Shockwave Medical announces new studies evaluating carotid IVL platform
Carotid artery disease causes up to 30% of all strokes, but severely calcified lesions can make treatment quite complex. The hope is that IVL can be as successful in this area as it has been in the treatment of coronary and peripheral artery disease.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Who is Anuk Karunaratne? Meet the Cardinals’ new President of Business Operations
The St. Louis Cardinals formally promoted Anuk Karunaratne to the role of President of Business Operations on Wednesday as the franchise unveiled changes to its organizational leadership structure.
Boone Health earns renewal of Level I STEMI Center designation for heart attack care
Boone Health earned its renewal of Level I STEMI (ST-Elevation Myocardial Infarction) Center designation, reaffirming their ability to provide the highest level
NFL offseason power rankings: No. 30 Arizona Cardinals restart the road to relevance, yet again
Highest June minimum temperature record broken in Cardiff as ‘savage’ heatwave continues
Thermometer only drops to 23.5C overnight in Welsh capital as climate crisis makes such extreme temperatures more severe and more likely
If Virginia’s ‘best state for business’ ranking falls, data center taxation debate will get the blame
But will Virginia fall? We don’t know yet, but we do know how CNBC has changed its formula. Here’s a look at whether that helps or hurts the state.
Latest COVID booster may offer bonus health benefit, study suggests
The latest COVID-19 vaccine (2024-2025) has been linked to fewer serious heart-related events among U.S. veterans. New research confirmed a small reduction in COVID-related cardiovascular events, or COVID-19-associated MACE, due to the vaccine.
20 everyday habits that affect your heart health
Cardiovascular disease is the world's leading cause of death — and most of its risk factors are behavioral, not genetic. These are the daily habits that matter most
FDA clears AI software for flagging signs of vascular disease
The newly cleared software alerts clinicians when it detects a suspected vascular occlusion.
Texas doctor charged in $89M fraud case as administration pushes health care crackdown
The Justice Department has charged a Texas doctor in an $89 million health care fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests.
Texas doctor charged in $89M fraud case as administration pushes healthcare crackdown
The Justice Department says it has charged a Texas doctor in an $89 million healthcare fraud scheme, accusing him of billing insurers for medically unnecessary cardiovascular screening tests for college student-athletes and then rubber-stamping the res...
New Boone Health cardiology clinic operations are steady
Boone Health served roughly 1,000 patients in the first two weeks following its split from the Missouri Heart Center in May.
Cardinals' Andre Pallante: Logs six innings in ninth win
Cardinals' Andre Pallante: Logs six innings in ninth win
Arizona Cardinals sign 4th-round pick, DL Kaleb Proctor
The Arizona Cardinals signed their fourth-round pick on Monday.
Arizona Cardinals officially sign Kaleb Proctor
The Arizona Cardinals have signed their fourth round pick.
Doctors Thought It Was Asthma. A.I. Flagged a Serious Heart Problem.
Artificial intelligence programs can spot patterns in electrocardiograms that humans miss. Now, one program is going to be widely available — for free — to doctors.
Private equity unlikely to dominate cardiology despite hype
Medaxiom CEO Jerry Blackwell, MD, MBA, FACC, discusses investor's interest in buying cardiology practices, noting that PE ownership remains relatively low.
Corewell Health and Champions of the Heart Foundation bring cardiac emergency response training to residents
Corewell Health and the Champions of the Heart Foundation are joining forces to expand emergency preparedness and lifesaving training across Michigan.
Cardiology groups strongly oppose expansion of Medicare AI prior authorization model
ASE, ASNC and SCAI have come out against a WiSER model using AI for traditional Medicare prior authorizations.
NYC Health + Hospitals/Elmhurst Pediatric Residents and Newtown High School Train Students and Teachers to Handle Cardiac Arrest
NYC Health + Hospitals/Elmhurst today announced its pediatric residents trained nearly 200 students and staff at Newtown High School in cardiac arrest
Penn State Health Milton S. Hershey Medical Center adopts “Heart-in-a-Box” technology to expand reach of donor hearts
Penn State Health Milton S. Hershey Medical Center has performed its first heart transplant using a new cardiac preservation technology that keeps donor hearts pumping outside the body…
Rams news: No felony charges, potential breakout player and more
Some stories about the NFC West rival LA Rams from the last week for Arizona Cardinals fans to know.
Seahawks news: Breakout candidates, top 100 lock, more fullback
Some stories about the NFC West rival Seattle Seahawks from the last week for Arizona Cardinals fans to know.
49ers news: Mike Evans impressing, rookies who impressed
Some stories about the NFC West rival San Francisco 49ers from the last week for Arizona Cardinals fans to know.
Scouting Stanford Guard Ebuka Okorie
Ebuka OkorieFrame: 6'2 185 lbsPosition: GuardTeam: Stanford Cardinals2026 Draft Age:Stats via https://www.sports-reference.com/cbb/players/ebuka-okorie-1.html Offense Ebuka Okorie emerged as one of the most productive freshman guards in the country and quickly transformed from an under-the-radar recruit into a legitimate NBA prospect. His offensive profile is built around dynamic scoring, relentless rim pressure, and advanced shot-making ability. Few
The Pulse: Women's Health is Having a Reckoning - The Longevity Gap is Where it Starts
Welcome to our new series The Pulse, covering everything you need to know about the age of intelligent health.From ovarian aging and maternal health to cardiovascular and dementia risk, HLTH USA 2026 is programming the women’s health conversations medicine has been too slow to have.While women live longer than men, they spend 25% longer in poor health. The healthspan gap, between how long women live and how long they live in good health, is the defining focus of the next frontier in women’s health. “Diminished healthspan ...
JJ Wetherholt Joins Paul Goldschmidt in Cardinals History
Cardinals rookie accomplished a feat not done in the organization for 20 years.
Want to Slow Your Aging? Multivitamins, Diet, and Fitness May Help
Recent research has explored the possible effects of diet, daily multivitamins, and cardiorespiratory fitness on aging. Learn about the findings here.
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals
Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...
‘A child goes to bed and doesn’t wake up’: the families left in shock after the sudden death of their healthy children
Sudden cardiac arrest is statistically rare but among the leading causes of death for children and young people. And families often have no idea of the risk until it’s too late
Cardinals' Nolan Gorman: Reworking swing away from games
Cardinals' Nolan Gorman: Reworking swing away from games
‘The Cardinal Countdown: 78 Days Until Kickoff’
CHARLIE EDGEWORTH #78 Height: 6’7” Weight: 320lb Position: OL Class: Freshman Hometown: Chattanooga, TN Summary: While its not right, and should not be acceptable in our country, I’m out here fighting the good fight and have yet to gain the momentum I need to avoid this blatant hate and bias. I’m of course talking about […]
Royals double their pleasure, double our fun against Cardinals
It’s KC’s second winning streak of three games in the month of June!
5 Foods Cardiologists Want Men to Eat More Often for Better Heart Health
Cardiologists share 5 foods men should eat more often for better heart health.
First US patient enrolled in device study to reduce coronary microvascular dysfunction
The self-expanding A-Flux device is implanted in the coronary sinus to increase pressure on the venous side of the heart and improve perfusion in smaller vessels.
Advances in leadless conduction and Bachmann’s bundle pacing next frontier in physiologic pacing
Leadless pacing in the Bachmann's bundle may be the next phase in the evolution of cardiac pacing technology.
Smartphones passively monitor heart health
Nature Reviews Electrical Engineering - A study in Nature uses deep learning to passively monitor resting heart rates via front-facing smartphone cameras, yielding highly accurate cardiovascular...
87 days till Arizona Cardinals' opener: Remembering the 1987 season
With 87 days until the Cardinals open the season, we look back at the 1987 season.
Do wearables actually help people with cardiovascular disease?
In this edition of STAT Health Tech: A look at what researchers found about if using wearables help people with cardiovascular diseases, and more.
4 Morning Habits A Cardiologist Avoids To Protect His Heart Health
In TODAY.com’s Expert Tip of the Day, a cardiologist reveals how morning habits can impact heart health and the best way to start the day.
Researchers found 8 common food additives linked to high blood pressure and heart disease
A major study of more than 112,000 people found that eating foods containing common preservatives may be linked to a higher risk of high blood pressure and heart-related diseases. Researchers tracked participants for up to eight years and discovered that people consuming the highest amounts of certain preservatives had significantly greater risks of hypertension, heart attack, stroke, and other cardiovascular problems.
More than 11K bottles of blood pressure drug recalled
Certain lots of a popular diuretic have been recalled due to concerns about the drug's effectiveness.
On Iran, Trump is committing the cardinal sin from the ‘Art of the Deal’
Toward the end of the Obama administration’s negotiations over its Iran nuclear deal in 2015, then-presidential candidate Donald Trump chimed in with some advice from his book, “The Art of the Deal.”
Local healthcare executive to lead 2026 Kern County Heart and Stroke Walk and county-wide push for CPR readiness
Bakersfield, Calif., June 17, 2026 — According to the American Heart Association, 9 in 10 people who suffer cardiac arrest outside of the hospital die, and more than half don’t receive bystander CPR. CPR — especially if performed immediately — can double...
Business for Good: Coblrshop for Your Vintage Glow-Up
What to do when your Eagle’s Eye cardigan or Rick Owens platform booties need a fix? A Fairmount entrepreneur has a convenient solution.
Cardinals expected to attend Brendan Sorsby's pro day
The Arizona Cardinals have already done plenty of homework on quarterback Brendan Sorsby, according to Arizona Sports' John Gambadoro.
'Not sustainable': The real impact of RVU cuts in electrophysiology
Despite a substantial increase in demand for electrophysiologists, payments for their services have remained stagnant.
Family files $17M lawsuit after young girl’s heart valve allegedly implanted upside down
Days went by and the girl's doctors allegedly never figured out what was wrong. When she was transferred to a different hospital, however, the issue was quickly identified and corrected.
CMS proposes major TAVR changes, including Medicare coverage for asymptomatic patients
After months of consideration, CMS has proposed sweeping changes to its TAVR coverage policies. The agency is accepting public comments until July 15.
Covid vaccine linked to broad protections against heart conditions, study finds
The vaccine modestly reduced cardiovascular conditions, hospitalizations and deaths of all causes, including those not linked to covid, researchers said.
A day in the life: President of Bacardi North America, Tony Latham
Tony Latham took over as president of Bacardi North America in April 2023 and moved to Miami. He prioritizes good sleep and living a balanced life.
Eric Topol
The famed cardiologist discusses how AI has transformed biomedical science
Arizona Cardinals OL Paris Johnson, Isaac Seumalo have simple communication
Cardinals LT Paris Johnson details how he and new LG Isaac Seumalo communicate on the field.
UC wins $3.3M grant to study microplastics' effects on cardiovascular health
Microplastics are in the food people eat, the water they drink and the air they breathe. UC researchers are studying the impact microplastics have on the heart.
Medline recalls nearly 50K procedure kits, including many used by cardiologists
This recall was put in place due to a risk of the included adhesive not working. Nothing needs to be returned, but clinicians should not use the adhesive that comes inside the procedure kits.
Medtronic completes $550M acquisition of neurovascular company
Scientia Vascular, a medtech company focused on advanced stroke therapies, is now officially part of Medtronic.
Fantasy Baseball 2-Start Pitcher Rankings: Cardinals, A's, Mets make rotation shuffles to open up more streaming options
Honoree focuses on heart health, urges resilience
Cardiologist Dr. Tara Narula will receive the American Heart Association&rsquo.
Stars react to Knicks NBA Finals win: Timothée disses Oscars, Cardi B screams, Ben Stiller sprints, and more
Timothée Chalamet shades the Oscars, Ben Stiller jumps into director more, Jennifer Lopez screams at the top of her lungs, and more in EW's roundup of the starriest reactions to the Knicks becoming NBA champions for the first time in 53 years.
Optimize health to combat cardiovascular disease
The threat of heart disease and stroke is growing substantially among women and girls as rates climb for health factors such as high blood pressure, diabetes and obesity, with 6
Who are the internal replacements for Cardinals trade chips?
Midway through June, I believe it is time we can all believe that the postseason is a real possibility for the St. Louis Cardinals this year. FanGraphs agrees, putting the Cardinals above a 50% chance to play in October, but we would still be smart to temper overall expectations for this season. The overall strategy […]
‘The Cardinal Countdown: 84 Days Until Kickoff’
PAYTON COOK #84 Height: 6’1” Weight: 190lb Position: WR Class: Freshman Hometown: Akron, OH Summary: Brohm and staff wanted to go secure some weapons in the high school ranks in 2026, and Cook was high on the list of bolstering up the arsenal. A near consensus four star player, Cook chose the Cards over Miami, […]
Why your cardiologist might tell you to skip AirPods
The magnetic fields emitted by your headphones will need to be used a safe distance away from your CIDs.
Game 71: Cardinals at Twins
A three-day homestand so the players can water their houseplants which they totally forgot to do before the road trip.
Cardinals Call-Up Top Prospect Infielder Amid Nolan Gorman News
The St. Louis Cardinals are calling up No. 25 prospect infielder Blaze Jordan to replace Nolan Gorman at third base.
FDA clears new computer-assisted device for removing clots in stroke patients
The Thunderbolt device from California-based Penumbra uses modulated aspiration to detect and remove blood clots. Back in January, Boston Scientific agreed to acquire Penumbra for approximately $14.5 billion.
Redo TAVR with balloon-expandable valves linked to positive outcomes, key improvements
Researchers tracked real-world data from more than 140 patients who originally received a transcatheter heart valve from Edwards Lifesciences, Medtronic or Boston Scientific.
Study finds 5 daily servings may fall short of key heart-health compounds
Researchers report that many people in the U.S. and U.K. are not consuming levels of flavanol-rich fruits and vegetables associated with better cardiovascular outcomes.
Austin’s young professionals community is red hot for heart health
AUSTIN, June 12, 2026 —Cardiovascular disease and stroke can affect anybody, of any age – and the young professionals community in Austin is turning up the heat to make sure everyone is prepared to save a life. The American Heart Association’s Young...
Health officials issue advisory about large gatherings as measles outbreak grows in Buckingham County
There have been 89 confirmed measles cases in the county this year.
Scientists found the strength training sweet spot for a longer life
Just 90–120 minutes of strength training a week may deliver some of the biggest long-term health rewards, according to a study tracking more than 147,000 people for 30 years. That amount was linked to lower risks of death overall, particularly from cardiovascular and neurological diseases. Combining strength workouts with aerobic exercise produced even stronger benefits.
Scientists found the strength training sweet spot for a longer life
Just 90–120 minutes of strength training a week may deliver some of the biggest long-term health rewards, according to a study tracking more than 147,000 people for 30 years. That amount was linked to lower risks of death overall, particularly from cardiovascular and neurological diseases. Combining strength workouts with aerobic exercise produced even stronger benefits.
Death after TAVR: New data support use of better patient assessments
A vast majority of patient deaths in the first year after TAVR have nothing to do with heart health. Could care teams be doing more to identify high-risk patients?
Mets Announce Another Roster Move Before Cardinals Game
The Mets are making another switch to their bullpen ahead of Thursday's game.
Using AI for medical advice; pelvic floor exercises; the hidden dangers of burning incense; plus other stories with Vanderbilt Health sources
Colin Walsh, MD,Associate Professor of Biomedical Informatics, was on WTVF News Channel 5‘s “Morningline” show in an interview about whether or not it is safe to use AI for medical advice. Time magazine reporter Stacey Colino interviewed Elisabeth Sebesta, MD, Assistant Professor of Urology, for a story about pelvic floor exercises for issues including menopause, erectile dysfunction and urinary incontinence in men. “Each Breath,” published by the American Lung Association, quoted Brian Christman, MD, Adjunct Professor of Medicine, for a story about the hidden dangers of burning incense. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Healthline (low vaccination rates lead to more cases of measles, whooping cough and other preventable diseases); ABC News (U.S. measles cases surpass 2,000 for second year in a row); and CIDRAP News (high-dose flu shots cut rates of hospitalization in older adults). Sarah Rohde, MD, Associate Professor of Otolaryngology-Head and Neck Surgery, was quoted in a People magazine story on patient Makalii Andrade, a surfer from Kauai Island who suffered a serious neck injury in 2022 and recently underwent surgery at Vanderbilt Health to begin the final phase of his recovery. James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a piece in Nature about antibodies against a strain of Ebola. SFGATE reporter Gillian Mohney interviewed Xue Zhong, PhD, Research Assistant Professor, Division of Genetic Medicine and Clinical Pharmacology, for a story about a study of a blood test looking at Alzheimer’s disease biomarkers. Matthew Franklin Mart, MD, Assistant Professor of Medicine, was quoted in a Healio story about how inflammation and illness severity is linked to less cognitive resilience after a person has been an ICU patient. The “How We Really Feel” podcast host Sula Windgassen, PhD, interviewed Lindsey C. McKernan, PhD, MPH, Associate Professor of Psychiatry & Behavioral Sciences, Physical Medicine & Rehabilitation and Urology, for an episode focusing on pelvic and bladder health. The podcast is also available on YouTube and the podcast website. In addition, podcaster Monica Sanford interviewed cardiologist Mark Glazer, MD, for her podcast “The Monica Sanford Show”; the two-part interview is here and here.
Heart Health Biotech Kardigan Seeks $373.3 Million in US IPO
Kardigan Inc. is seeking to raise $373.3 million in a US initial public offering to help fund three late-stage drugs that target cardiovascular diseases.
Mets suffer another noncompetitive loss to Cardinals
The Mets looked terrible once again.
Charles Barkley dares ESPN to fire him after his controversial Cardi B joke during NBA Finals
Charles Barkley reacted to the controversy surrounding the joke he made about Cardi B during the NBA Finals.
PAD patients minimize risk when they listen to their doctors
Patients who exercise and take all prescribed medications, for instance, experience better outcomes than those who do not.
Visceral fat loss associated with better long-term cardiometabolic, cognitive health | Harvard T.H. Chan School of Public Health
Irrespective of weight loss, maintaining a lower level of visceral fat—fat stored deep within the abdomen, wrapping around vital organs—may lead to better long-term cardiometabolic and cognitive health, according to two new Harvard Chan School studies.
Staying heart healthy and low-stress amid NBA Finals
Dr. Shaline Rao, Chief of Cardiology at NYU Langone Hospital-Long Island, gives tips on staying healthy while watching the Knicks.
Arizona Cardinals' made big offseason mistake to cause current problems
The Arizona Cardinals' situation with Jacoby Brissett was their own fault for a premature QB decision in the spring.